Reciprocal regulation of the neural and innate immune systems

Michael R Irwin, Steven W Cole, Michael R Irwin, Steven W Cole

Abstract

Innate immune responses are regulated by microorganisms and cell death, as well as by a third class of stress signal from the nervous and endocrine systems. The innate immune system also feeds back, through the production of cytokines, to regulate the function of the central nervous system (CNS), and this has effects on behaviour. These signals provide an extrinsic regulatory circuit that links physiological, social and environmental conditions, as perceived by the CNS, with transcriptional 'decision-making' in leukocytes. CNS-mediated regulation of innate immune responses optimizes total organism fitness and provides new opportunities for therapeutic control of chronic infectious, inflammatory and neuropsychiatric diseases.

Figures

Figure 1. CNS regulation of innate immune…
Figure 1. CNS regulation of innate immune response gene programmes
a | The hypothalamic–pituitary–adrenal (HPA) axis distributes glucocorticoid hormones through the blood to regulate gene expression in virtually every cell of the body. Hormone activation of the glucocorticoid receptor in leukocytes results in profound suppression of both pro-inflammatory gene networks (for example, NF-κB-mediated transcription of pro-inflammatory cytokine genes, such as IL1B, IL6 and TNF) and antiviral gene programmes (for example, IRF-mediated transcription of type I interferon (IFN) genes, such as IFNA and IFNB). Activation of cytokine receptors in the hypothalamus triggers the production of glucocorticoids by the HPA axis. This constitutes the body’s primary systemic mechanism for negative feedback control of pro-inflammatory gene expression triggered by microbial pattern recognition receptors (PRRs). b | During fight-or-flight responses and acute injury, nerve fibres from the sympathetic nervous system (SNS) release the neurotransmitter noradrenaline into primary and secondary lymphoid organs, all other major organ systems (including the vasculature and perivascular tissues) and many peripheral tissues in which pro-inflammatory reactions occur. SNS nerve fibres can also stimulate the adrenal glands to release stored adrenaline into the systemic circulation. Both of these neuromediators regulate vascular function and stimulate leukocyte adrenergic receptors (for example, ADRB2) to activate transcription factors such as CREB and GATA family factors. SNS-induced transcriptional alterations can modulate haematopoiesis, redeploy leukocytes between tissue and blood, and repress IRF-mediated antiviral immune response gene programmes while enhancing many NF-κB-mediated pro-inflammatory programmes. ACTH, adrenocorticotropic hormone; ADRB2, β2-adrenergic receptor; CRH, corticotropin-releasing hormone; IL, interleukin; IRF, interferon regulatory factor; NF-κB, nuclear factor-κB; TNF, tumour necrosis factor.
Figure 2. Multi-circuit control of the innate…
Figure 2. Multi-circuit control of the innate immune transcriptome
Leukocyte transcription of immune response gene programmes is regulated by both intrinsic immunological signals representing local tissue and microbial conditions and extrinsic neural and endocrine signals representing global physiological and environmental conditions. Intrinsic circuits detect microorganisms via pattern recognition receptors (PRRs) and stimulate pro-inflammatory and antiviral immune response gene programmes via transcription factors such as nuclear factor-κB (NF-κB) and interferon regulatory factors (IRFs). The resulting production of innate immune effector molecules reduces microbial burden, and thereby feeds back to reduce PRR and antigen receptor signalling and immune response gene transcription. Extrinsic regulation of immune response gene transcription is mediated by central nervous system (CNS) integration of information regarding general physiological and ecological conditions. This can either globally suppress immune response gene transcription via the hypothalamic–pituitary–adrenal axis or steer immune response gene transcriptional profiles away from antiviral programmes and towards more robust pro-inflammatory gene expression. CNS-mediated transduction of information from the social and physical ecology allows extra-organismal environmental conditions to indirectly regulate the immune response gene transcriptional profiles of immune cells. SNS, sympathetic nervous system.

References

    1. Matzinger P. Friendly and dangerous signals: is the tissue in control? Nature Immunol. 2007;8:11–13.
    1. Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: implications for health. Nature Rev. Immunol. 2005;5:243–251.
    1. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Rev. Neurosci. 2008;9:46–56.
    1. McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 2007;87:873–904.
    1. Powell ND, Mays JW, Bailey MT, Hanke ML, Sheridan JF. Immunogenic dendritic cells primed by social defeat enhance adaptive immunity to influenza A virus. Brain Behav. Immun. 2011;25:46–52.
    1. Cole SW, Hawkley LC, Arevalo JM, Cacioppo JT. Transcript origin analysis identifies antigen-presenting cells as primary targets of socially regulated gene expression in leukocytes. Proc. Natl Acad. Sci. USA. 2011;108:3080–3085.
    1. Cohen S, Janicki-Deverts D, Miller GE. Psychological stress and disease. JAMA. 2007;298:1685–1687.
    1. Amit I, et al. Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science. 2009;326:257–263.
    1. Decker T, Muller M, Stockinger S. The yin and yang of type I interferon activity in bacterial infection. Nature Rev. Immunol. 2005;5:675–687.
    1. Finch CE. Evolution in health and medicine Sackler colloquium. Evolution of the human lifespan and diseases of aging: roles of infection, inflammation, and nutrition. Proc. Natl Acad. Sci. USA. 2010;1:1718–1724.
    1. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science. 1987;238:522–524.
    1. Berkenbosch F, VanOers J, DelRey A, Tilders F, Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science. 1987;238:524–526.
    1. Besedovsky H, del Rey A, Sorkin E, Dinarello CA. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science. 1986;233:652–654.
    1. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids — new mechanisms for old drugs. N. Engl. J. Med. 2005;353:1711–1723.
    1. Pace TW, Hu F, Miller AH. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav. Immun. 2007;21:9–19.
    1. Cole S, et al. Computational identification of gene–social environment interaction at the human IL6 locus. Proc. Natl Acad. Sci. USA. 2010;107:5681–5686.
    1. Collado-Hidalgo A, Sung C, Cole S. Adrenergic inhibition of innate anti-viral response: PKA blockade of type I interferon gene transcription mediates catecholamine support for HIV-1 replication. Brain Behav. Immun. 2006;20:552–563.
    1. Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987–2007) Brain Behav. Immun. 2007;21:736–745.
    1. Lee HJ, et al. GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells. J. Exp. Med. 2000;192:105–115.
    1. Panina-Bordignon P, et al. β2-agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 1997;100:1513–1519.
    1. Cole SW, Korin YD, Fahey JL, Zack JA. Norepinephrine accelerates HIV replication via protein kinase A-dependent effect on cytokine production. J. Immunol. 1998;161:610–616.
    1. Grebe KM, et al. Cutting edge: sympathetic nervous system increases proinflammatory cytokines and exacerbates influenza A virus pathogenesis. J. Immunol. 2009;184:540–544.
    1. Cole SW, et al. Social regulation of gene expression in human leukocytes. Genome Biol. 2007;8:1–13.
    1. Sloan EK, et al. Social stress enhances sympathetic innervation of primate lymph nodes: mechanisms and implications for viral pathogenesis. J. Neurosci. 2007;27:8857–8865.
    1. Kiecolt-Glaser JK, et al. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc. Natl Acad. Sci. USA. 2003;100:9090–9095.
    1. Miller GE, et al. A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-κB signaling. Biol. Psychiatry. 2008;64:266–272.
    1. Pace TW, et al. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am. J. Psychiatry. 2006;163:1630–1633.
    1. Bierhaus A, et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc. Natl Acad. Sci. USA. 2003;100:1920–1925.
    1. Goebel MU, Mills PJ, Irwin MR, Ziegler MG. Interleukin-6 and tumor necrosis factor-α production after acute psychological stress, exercise, and infused isoproterenol: differential effects and pathways. Psychosom. Med. 2000;62:591–598.
    1. Bower JE, et al. Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids. Brain Behav. Immun. 2007;21:251–258.
    1. Richlin VA, Arevalo JM, Zack JA, Cole SW. Stress-induced enhancement of NF-κB DNA-binding in the peripheral blood leukocyte pool: effects of lymphocyte redistribution. Brain Behav. Immun. 2004;18:231–237.
    1. Miller GE, et al. Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling. Proc. Natl Acad. Sci. USA. 2009;106:14716–14721.
    1. Engler H, Bailey MT, Engler A, Sheridan JF. Effects of repeated social stress on leukocyte distribution in bone marrow, peripheral blood and spleen. J. Neuroimmunol. 2004;148:106–115.
    1. Wohleb ES, et al. β-adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J. Neurosci. 2011;31:6277–6288.
    1. Chen E, et al. Genome-wide transcriptional profiling linked to social class in asthma. Thorax. 2009;64:38–43.
    1. Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch. Intern. Med. 2006;166:1756–1762.
    1. Irwin MR, et al. Sleep loss activates cellular inflammatory signaling. Biol. Psychiatry. 2008;64:538–540.
    1. Motivala S, Irwin MR. Sleep and immunity: cytokine pathways linking sleep and health outcomes. Curr. Dir. Psychol. Sci. 2007;16:21–25.
    1. Meier-Ewert HK, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J. Am. Coll. Cardiol. 2004;43:678–683.
    1. Irwin MR, Carrillo C, Olmstead R. Sleep loss activates cellular markers of inflammation: sex differences. Brain Behav. Immun. 2010;24:54–57.
    1. O’Connor MF, Motivala SJ, Valladares EM, Olmstead R, Irwin MR. Sex differences in monocyte expression of IL-6: role of autonomic mechanisms. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007;293:R145–R151.
    1. Watkins LR, Maier SF. Implications of immune-to-brain communication for sickness and pain. Proc. Natl Acad. Sci. USA. 1999;96:7710–7713.
    1. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry. 2009;65:732–741.
    1. Hart BL. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 1988;12:123–137.
    1. Harrison NA, et al. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol. Psychiatry. 2009;66:407–414.
    1. Eisenberger NI, Inagaki TK, Rameson LT, Mashal NM, Irwin MR. An fMRI study of cytokine-induced depressed mood and social pain: the role of sex differences. Neuroimage. 2009;47:881–890.
    1. Eisenberger NI, et al. Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol. Psychiatry. 2010;68:748–754.
    1. Gimeno D, et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol. Med. 2009;39:413–423.
    1. Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR. Neuroendocrine–immune mechanisms of behavioral comorbidities in patients with cancer. J. Clin. Oncol. 2008;26:971–982.
    1. Capuron L, et al. Neurobehavioral effects of interferon-α in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology. 2002;26:643–652.
    1. Capuron L, Ravaud A, Dantzer R. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon α-2b therapy. J. Clin. Oncol. 2000;18:2143–2151.
    1. Tyring S, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet. 2006;367:29–35.
    1. Wong ML, Dong C, Maestre-Mesa J, Licinio J. Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol. Psychiatry. 2008;13:800–812.
    1. Benedetti F, Lucca A, Brambilla F, Colombo C, Smeraldi E. Interleukin-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2002;26:1167–1170.
    1. Raison CL, Lowry CA, Rook GA. Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression. Arch. Gen. Psychiatry. 2010;67:1211–1224.
    1. Imeri L, Opp MR. How (and why) the immune system makes us sleep. Nature Rev. Neurosci. 2009;10:199–210.
    1. Mullington J, et al. Dose-dependent effects of endotoxin on human sleep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000;278:R947–R955.
    1. Raison CL, et al. Chronic interferon-α administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol. Biol. Psychiatry. 2010;68:942–949.
    1. Vgontzas AN, et al. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-α antagonist. J. Clin. Endocrinol. Metab. 2004;89:4409–4413.
    1. Monk JP, et al. Assessment of tumor necrosis factor α blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. J. Clin. Oncol. 2006;24:1852–1859.
    1. Irwin MR, Olmstead R, Valladares EM, Breen EC, Ehlers CL. Tumor necrosis factor antagonism normalizes rapid eye movement sleep in alcohol dependence. Biol. Psychiatry. 2009;66:191–195.
    1. Dew MA, et al. Healthy older adults’ sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom. Med. 2003;65:63–73.
    1. Thomas KS, Motivala S, Olmstead R, Irwin MR. Sleep depth and fatigue: role of cellular inflammatory activation. Brain Behav. Immun. 2011;25:53–58.
    1. Cho HJ, Seeman TE, Bower JE, Kiefe CI, Irwin MR. Prospective association between C-reactive protein and fatigue in the coronary artery risk development in young adults study. Biol. Psychiatry. 2009;66:871–878.
    1. Heesen C, et al. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J. Neurol. Neurosurg. Psychiatry. 2006;77:34–39.
    1. Harboe E, et al. Fatigue in primary Sjogren’s syndrome — a link to sickness behaviour in animals? Brain Behav. Immun. 2009;23:1104–1108.
    1. Davis MC, et al. Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: implications for fatigue. Brain Behav. Immun. 2008;22:24–32.
    1. Schubert C, Hong S, Natarajan L, Mills PJ, Dimsdale JE. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav. Immun. 2007;21:413–427.
    1. Bower JE, et al. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin. Cancer Res. 2009;15:5534–5540.
    1. Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin. Cancer Res. 2006;12:2759–2766.
    1. Bower JE, Ganz PA, Irwin MR, Arevalo JM, Cole SW. Fatigue and gene expression in human leukocytes: increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain Behav. Immun. 2011;25:147–150.
    1. Collado-Hidalgo A, Bower JE, Ganz PA, Irwin MR, Cole SW. Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings. Brain Behav. Immun. 2008;22:1197–1200.
    1. Zautra AJ, et al. Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression. J. Consult. Clin. Psychol. 2008;76:408–421.
    1. Nicklas BJ, et al. Exercise training and plasma C-reactive protein and interleukin-6 in elderly people. J. Am. Geriatr. Soc. 2008;56:2045–2052.
    1. Pace TW, et al. Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology. 2009;34:87–98.
    1. Irwin MR, Olmstead R. Mitigating cellular inflammation in older adults. Am. J. Geriatr. Psychiatry. (in the press)
    1. Lavretsky H, et al. Complementary use of Tai Chi Chih augments escitalopram treatment of geriatric depression: a randomized controlled trial. Am. J. Geriatr. Psychiatry. 2011 Mar 6;
    1. Sloan EK, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010;70:7042–7052.
    1. Idaghdour Y, et al. Geographical genomics of human leukocyte gene expression variation in southern Morocco. Nature Genet. 2010;42:62–67.
    1. Ericsson A, Kovacs KJ, Sawchenko PE. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J. Neurosci. 1994;14:897–913.
    1. Cole SW. In: Complex Systems Science in Biomedicine. Deisboeck TS, Kresh JY, editors. New York: Springer; 2006. pp. 605–629.

Source: PubMed

3
Iratkozz fel